ConductScience.org, home

Paper2297774

Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.

Molinolo A and 3 others. Cancer Res, 1990. Cited by 104 papers, by iCite.

Cite this record

ConductScience Library. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Papers, record 2297774. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2297774

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
PubMed
Journal
Cancer Res
PubMed
Year
1990
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
3.17
iCite
Revised in PubMed
2006-11-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Molinolo AA
2Simpson JFJ F
3Thor AA
4Schlom JJ

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antigens, NeoplasmMajor topic
Colorectal NeoplasmsMajor topic
GlycoproteinsMajor topic
Stomach NeoplasmsMajor topic
Adenocarcinoma
Humans
Lung

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
34950576Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action.Front Oncol2021https://conductscience.org/library/papers/34950576PubMed
32368864Improved targeting of an anti-TAG-72 antibody drug conjugate for the treatment of ovarian cancer.Cancer Med2020https://conductscience.org/library/papers/32368864PubMed
28344808Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.J Immunother Cancer2017https://conductscience.org/library/papers/28344808PubMed
25727152Glycosylation alterations in lung and brain cancer.Adv Cancer Res2015https://conductscience.org/library/papers/25727152PubMed
24175669Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.Bioconjug Chem2013https://conductscience.org/library/papers/24175669PubMed
21461170Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.Transl Oncol2011https://conductscience.org/library/papers/21461170PubMed
19718796Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.Mol Pharm2009https://conductscience.org/library/papers/19718796PubMed
8384409Carcinomas of Bartholin's gland. Histogenesis and the etiological role of human papillomavirus.Am J Pathol1993https://conductscience.org/library/papers/8384409PubMed
8367454Secretion of a single-gene-encoded immunoglobulin from myeloma cells.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8367454PubMed
8270610High-affinity chimeric anti-(colorectal carcinoma) antibody correlated to enhanced tumor targeting in biodistribution and imaging.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8270610PubMed
7508339
Epitope masking of rat esophageal carcinoma tumor-associated antigen by certain coexisting glycolipid and phospholipid molecules: a potential mechanism for tumor cell escape from the host immune responses.
Cancer Immunol Immunother1994https://conductscience.org/library/papers/7508339PubMed
2248992Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.Biophys J1990https://conductscience.org/library/papers/2248992PubMed
1597401Targeting antibodies to live tumor tissue in 3-D histoculture.In Vitro Cell Dev Biol1992https://conductscience.org/library/papers/1597401PubMed
1551684Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.Immunology1992https://conductscience.org/library/papers/1551684PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2297774

GET https://conductscience.org/api/papers/v1/2297774/authors